Schedule 13D ownership disclosure

HUMACYTE INC

Security class unavailable · CUSIP: 44486Q103

Event date: 2024-03-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,153,195
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001818382-24-000029
Form type
SC 13D/A
Filer
Humacyte, Inc.
CIK
CIK 1818382
Filed
Mar 08, 2024
Reporting period
Mar 05, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub